MarketPulse

stock price decline

271 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

AQST Stock Plunged 37% After FDA Setback; Securities Lawsuit Deadline Looms May 4

Aquestive Therapeutics faces securities class action over alleged false FDA approval statements for Anaphylm drug. Stock fell 37% after January 2026 NDA rejection.
AQSTsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Camping World Holdings Faces Securities Lawsuit Over Inventory Claims

Securities class action filed against $CWH for allegedly misleading statements on inventory management. Stock fell sharply in Q3-Q4 2025; investor deadline set for May 11, 2026.
CWHsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Nektar Therapeutics Hit With Securities Class Action Over Failed Trial Disclosures

Nektar faces securities litigation over alleged misstatements about REZOLVE-AA trial enrollment practices. Stock fell 7.77% after trial failure announcement.
NKTRsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Energy Storage Firm EOSE Faces Securities Suit Over Major Revenue Miss

Eos Energy Enterprises faces securities class action over $35.8M revenue shortfall, missing 2025 guidance by 24-30%. Stock fell 39.4%; investors have until May 5, 2026 to join suit.
EOSEguidance misssecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Ultragenyx Stock Tumbles on Failed Drug Trials; Class Action Deadline Looms

Securities class action filed against $RARE over alleged misstatements about setrusumab drug efficacy. Failed clinical trials triggered 25-42% stock declines. Investor deadline: April 6, 2026.
RAREsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Navan Faces Securities Lawsuit Over Concealed Marketing Spending Surge

Navan investors sue over allegedly misleading IPO disclosures. Stock crashed 63% after surprise 39% sales expense hike revealed.
NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Driven Brands Faces Class Action Over $DRVN Financial Restatement; Stock Plummets 40%

Driven Brands ($DRVN) faces class action lawsuit over accounting errors in fiscal 2023-2025 statements. Stock fell 40% after February disclosure. Investors can seek lead plaintiff status.
DRVNsecurities fraudclass action lawsuit
BenzingaBenzinga··The Law Offices Of Frank R. Cruz

IperionX Stock Plunges 16% After $17.7M Accounting Error Sparks Fraud Investigation

$IPX crashed 16% after disclosing a $17.7M carrying amount misstatement in financial reports. Securities fraud investigation launched for affected shareholders.
IPXsecurities fraudinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

ODDITY Tech Stock Crashes 49% After Disclosure of Hidden Ad Partner Algorithm Changes

ODDITY Tech faces class action lawsuit alleging concealment of ad partner algorithm changes that inflated customer acquisition costs. Stock fell 49% after CEO disclosure on February 25.
ODDsecurities fraudclass action lawsuit
BenzingaBenzinga··Law Offices Of Howard G. Smith

DRVN Plummets 30% After Accounting Restatement; Class Action Deadline Looms

Driven Brands ($DRVN) stock plummets 30.2% after disclosing multi-year accounting errors. Class action deadline set for May 8, 2026.
DRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Kessler Topaz Meltzer & Check, Llp

Kyndryl Faces Securities Fraud Suit Over Control Failures; Stock Crashed 54%

Kyndryl ($KD) faces class action lawsuit alleging material misstatements on controls. Stock plunged 54% after CFO, General Counsel departures and SEC disclosure.
KDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Llp

$TCOM Faces Securities Fraud Lawsuit Over Concealed Antitrust Risks

Trip.com faces securities fraud class action for allegedly understating regulatory risks. Stock fell 17% after China's antitrust investigation was revealed in January 2026.
TCOMsecurities fraudregulatory risk
BenzingaBenzinga··Business Wire

Driven Brands Faces Securities Fraud Suit Over $11.6B Financial Restatement

Driven Brands faces securities fraud class action over material accounting errors spanning 2023-2026. Stock fell 30.2% following disclosure.
DRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Eos Energy Stock Plummets 39% After Missing Revenue Guidance by $36M

Eos Energy stock drops 39% after missing $150-160M guidance with $114.2M revenue. Securities fraud lawsuit filed by Glancy Prongay Wolke & Rotter.
EOSEsecurities fraudclass action lawsuit
BenzingaBenzinga··Business Wire

Nektar Therapeutics Faces Securities Fraud Investigation After Failed Trial Announcement

Law firm investigates $NKTR over December trial failure disclosure. Stock dropped 7.8% after alopecia areata Phase 2b study missed endpoints due to ineligible patients.
NKTRshareholder lawsuitstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

Ultragenyx Stock Collapses 42% After Clinical Trial Failure, Class Action Deadline Looms

Ultragenyx Pharmaceutical's stock plunged 42% after failing to disclose setrusumab Phase 3 trial failure, triggering securities litigation with April 6, 2026 lead plaintiff deadline.
RAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Hub Group Accounting Error Sparks 18% Stock Plunge, Legal Scrutiny

Hub Group discloses accounting error understating costs, triggering 18.3% stock plunge and securities litigation investigation.
HUBGsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

uniQure Stock Crashes 49% on FDA Setback; Class Action Deadline Looms

uniQure faces securities lawsuit after FDA rejected AMT-130 approval pathway. Stock plummeted 49% following disclosure. Lead plaintiff deadline: April 13, 2026.
QUREsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

Kyndryl Faces Major Securities Lawsuit After 55% Stock Collapse on Control Failures

Kyndryl Holdings faces securities class action over undisclosed internal control weaknesses. Stock plunged 55% after February 2026 disclosure; lead plaintiff deadline set for April 13.
KDsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

$CORT Plummets 50% After FDA Rejection; Class Action Deadline Looms for Major Shareholders

$CORT stock plummets 50% after FDA rejects lead drug relacorilant; class action targets alleged disclosure failures with lead plaintiff deadline April 21, 2026.
CORTsecurities fraudclass action lawsuit